Bodyport

bodyport.com
970 Folsom St
San Francisco, CA 94107

Company Info

Year Established
2015

Contacts

John Lipman
CEO

Sarah Smith
Co-Founder

Corey Centen
Co-Founder, President & CTO

Daniel Yazdi, MD, MS
Medical Director

Company Description

Bodyport's cardiovascular sensing weight scale and predictive algorithms detect early changes in cardiac function to help prevent avoidable hospitalizations.

Transfection Has Never Been So Easy With Avalanche® Transfection Reagents for Cancer Cells, Primary Cells, And Other Difficult-To-Transfect Cells.Primary Cells, And Other Difficult-To-Transfect Cells.